|
Volumn 3, Issue 3, 2001, Pages 331-333
|
Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARVEDILOL;
VASCULOTROPIN;
ADULT;
ANGIOGENESIS;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY CONSTRICTION;
DOUBLE BLIND PROCEDURE;
FEMALE;
HEART FAILURE;
HEART MUSCLE ISCHEMIA;
HUMAN;
ISCHEMIC HEART DISEASE;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VERTIGO;
ADRENERGIC BETA-ANTAGONISTS;
ATRIAL NATRIURETIC FACTOR;
BLOOD PRESSURE;
CARBAZOLES;
CHRONIC DISEASE;
DOUBLE-BLIND METHOD;
ENDOTHELIAL GROWTH FACTORS;
FEMALE;
HEART FAILURE, CONGESTIVE;
HEART RATE;
HUMANS;
LYMPHOKINES;
MALE;
MIDDLE AGED;
PROPANOLAMINES;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 0034828069
PISSN: 13889842
EISSN: None
Source Type: Journal
DOI: 10.1016/S1388-9842(01)00129-5 Document Type: Article |
Times cited : (21)
|
References (14)
|